Your cells use the HSPD1 gene to fold proteins into the right shape, especially in mitochondria, the parts of cells that make energy. This gene plays an important role in keeping nerve and muscle cells working smoothly. If it does not work well, cells may have trouble making energy and handling stress, which can contribute to rare inherited conditions with weakness, movement problems, or delays in development. Many variants in this gene are harmless, while a few clearly disrupt its function.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for building proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes take place, where they occur, and how strongly they operate. As a group, genes influence how the body develops and works, and they can affect how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
HSPD1Gene function
What if the gene works
The HSPD1 gene helps make a protein that folds other proteins inside mitochondria, the parts of cells that produce energy. This supports energy production and routine cell health.
Risk
What if the gene does not work
Variants in the HSPD1 gene are linked to nerve conditions, including hereditary spastic paraplegia and, in more severe cases, hypomyelinating leukodystrophy. Milder or more severe variants can affect when symptoms start and how much movement and development are affected.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the HSPD1 gene, no HSPD1-specific treatment or drug choice approach is currently established in clinical guidelines. The HSPD1 gene is being studied as a possible biomarker and drug target in some cancers, but this has not led to routine treatment guidance.
Conditions associated with HSPD1
Gene function
What if the gene works
Inside your cells, the HSPD1 gene helps proteins in mitochondria reach the right shape so they can work. Mitochondria are the parts of cells that make most of your energy. Understanding HSPD1 gene function helps show how cells keep everyday energy production steady.
The HSPD1 gene helps newly made proteins inside mitochondria fold into the right shape. This lets many mitochondrial proteins become stable and ready for use.
Many proteins that help turn food into energy rely on support from the HSPD1 gene after they enter mitochondria. By helping these enzymes mature, it supports steady energy production for daily tasks such as movement and thinking.
The HSPD1 gene also helps refold proteins that become misshapen during normal cell stress, such as fever or periods of high energy use. This helps mitochondria stay organized and keeps their protein tools working smoothly.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the HSPD1 gene can make the HSP60 protein less stable or less able to fold other proteins properly inside mitochondria, the cell’s energy centers. Some HSPD1 gene variants only partly reduce this activity, while more severe variants can strongly disrupt protein assembly or leave very little working protein. This difference can influence whether HSPD1-related neurologic symptoms are milder and appear later, or begin earlier and affect more functions.
How variants are linked to conditions
Pathogenic variants in the HSPD1 gene can cause two rare inherited neurologic conditions: spastic paraplegia 13 and hypomyelinating leukodystrophy 4. Spastic paraplegia 13 mainly affects walking and leg stiffness, while hypomyelinating leukodystrophy 4 usually starts earlier and can include delayed development, muscle weakness, and vision or movement problems. These are the main health conditions linked to HSPD1 gene variants, while most common HSPD1 variants found on broader testing are not known to cause these diagnoses on their own.
A variant is not necessarily a diagnosis
Gene changes are a normal part of human biology and are common throughout the general population. Most variants do not have a direct effect on health and simply add to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For HSPD1, risk is mainly shaped by the gene change itself and whether it runs in your family. There is not yet broadly confirmed evidence that lifestyle or environmental factors clearly increase or lower risk related to HSPD1.
Inheritance of HSPD1 variants
For HSPD1-related conditions, how HSPD1 gene variants are inherited depends on the specific condition and variant. Some HSPD1 gene changes are inherited in an autosomal dominant pattern, which means one altered copy from either parent can be enough to cause the condition and each child has a 50% chance of inheriting that variant. Other HSPD1 gene changes follow an autosomal recessive pattern, which means a child inherits one altered copy from each parent, while carrier parents are often unaffected and each pregnancy has a 25% chance of an affected child. This means HSPD1 inheritance is not described by a single pattern for all families.
What does my HSPD1 result mean for my family?
HSPD1 results can have different meanings for family members because this gene has been linked to more than one inherited condition. In some families, a changed HSPD1 copy can be passed from an affected parent, so close relatives may also carry it and may be at risk; in others, both parents may be healthy carriers, which can matter for brothers, sisters, and future children. The family impact depends on the exact HSPD1 change and the condition tied to it.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for HSPD1 variants usually uses a blood or saliva sample. A lab reads the HSPD1 gene to look for changes that may help explain certain inherited nerve or movement conditions. Results may show a disease-causing variant, a benign variant, or an unclear finding that needs careful clinical interpretation.
When should I consider getting a genetic test?
Genetic testing for the HSPD1 gene may be worth considering when a child or adult has unexplained movement and nerve problems, such as muscle stiffness, weakness, delayed development, or brain scan changes in the brain’s white matter. It can also help when similar problems seem to run in the family.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the specific variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes that help the body absorb, break down, move, or respond to a drug can mean that the same treatment works well for one person but less well for another. These differences are common and can influence how much benefit someone gets or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This understanding can support more informed and individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the HSPD1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or response in routine care. If you have side effects, unusual reactions, or questions about how a medicine fits with your overall health, it is a good time to speak with your doctor.
History
In recent decades, awareness of the HSPD1 gene’s role has grown through research on heat shock proteins, a group first recognized when scientists noticed cells making specific proteins under stress. HSPD1 was identified as the human counterpart of a well known bacterial protein called GroEL, linking work in basic microbiology with human genetics. From these first observations, research expanded steadily into mitochondrial disease, where rare HSPD1 variants were later tied to inherited nerve and movement conditions. This helped connect laboratory studies of protein folding with symptoms seen in families. The way this gene was viewed has shifted over time, from a general stress related protein to one with a clear place in clinical genetics.